We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$4.18B
AUM Growth
+$413M
Cap. Flow
+$293M
Cap. Flow %
7.01%
Top 10 Hldgs %
6.7%
Holding
1,500
New
123
Increased
567
Reduced
324
Closed
123

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$20M
2
NVDA icon
NVIDIA
NVDA
+$19M
3
JNJ icon
Johnson & Johnson
JNJ
+$14.9M
4
KO icon
Coca-Cola
KO
+$14.6M
5
MSFT icon
Microsoft
MSFT
+$13.7M

Sector Composition

Rank Sector Weight
1 Financials 24.63%
2 Consumer Discretionary 12.15%
3 Technology 12.08%
4 Industrials 12%
5 Healthcare 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRNA
1476
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
-145,000
Closed -$62.7K
IMBI
1477
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
-44,817
Closed -$22.8K
EVLO
1478
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
-5,265
Closed -$19K
ONCR
1479
DELISTED
Oncorus, Inc.
ONCR
-67,300
Closed -$23.2K
HVBC
1480
DELISTED
HV Bancorp, Inc. Common Stock
HVBC
-9,510
Closed -$286K
UNAM
1481
DELISTED
Unico American Corp
UNAM
-54,500
Closed -$56.7K
STSA
1482
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
-120,300
Closed -$84K
DBD
1483
DELISTED
Diebold Nixdorf Incorporated
DBD
-189,600
Closed -$228K
ACOR
1484
DELISTED
Acorda Therapeutics
ACOR
-3,835
Closed -$45K
TCRR
1485
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-181,810
Closed -$273K
LABP
1486
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
-3,900
Closed -$11.6K
IDW
1487
DELISTED
IDW Media Holdings
IDW
-35,500
Closed -$25.6K
BIOC
1488
DELISTED
Biocept, Inc.
BIOC
-3,140
Closed -$32K
TA
1489
DELISTED
TravelCenters of America LLC
TA
-248,371
Closed -$21.5M
MAXR
1490
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
-83,000
Closed -$4.24M
LMST
1491
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
-58,275
Closed -$1.3M
TIG
1492
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
-208,510
Closed -$1.28M
APEN
1493
DELISTED
Apollo Endosurgery, Inc.
APEN
-175,200
Closed -$1.74M
AGFS
1494
DELISTED
AgroFresh Solutions Inc
AGFS
-514,392
Closed -$1.54M
ATNX
1495
DELISTED
Athenex, Inc. Common Stock
ATNX
-11,700
Closed -$15.6K
LCI
1496
DELISTED
Lannett Company, Inc.
LCI
-29,799
Closed -$51.9K
CHRA
1497
DELISTED
Charah Solutions, Inc Common Stock
CHRA
-17,270
Closed -$36.1K
NH
1498
DELISTED
NantHealth, Inc
NH
-18,432
Closed -$37K
SRGA
1499
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
-25,000
Closed -$40K
NAVB
1500
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
-102,440
Closed -$26.6K

Similar funds

Bridgeway Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Bridgeway Capital Management held 1,500 positions worth $4.18B, up 11% from $3.77B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Bridgeway Capital Management deployed $293M of net new capital in Q2 2023, opening 123 new positions and adding to 567 existing holdings. Its largest new stake was Tronox: 919,025 shares worth $11.7M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Permian Resources, an estimated $14.3M trimmed.

  • Bridgeway Capital Management's largest Q2 2023 buy was Tronox: 919,025 shares worth $11.7M.
  • Bridgeway Capital Management added most to JPMorgan Chase in Q2 2023, an estimated $20M increase.
  • Bridgeway Capital Management's biggest Q2 2023 reduction was Permian Resources, cutting an estimated $14.3M.
  • Bridgeway Capital Management fully exited TravelCenters of America LLC in Q2 2023, selling an estimated $21.5M.
  • Bridgeway Capital Management's ten largest holdings make up 6.7% of its $4.18B portfolio in Q2 2023.
  • Bridgeway Capital Management opened 123 new positions and closed 123 in Q2 2023.
  • Bridgeway Capital Management's portfolio value rose 11% quarter-over-quarter to $4.18B.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.